172 related articles for article (PubMed ID: 15656915)
1. Upregulated expression of human neutrophil peptides 1, 2 and 3 (HNP 1-3) in colon cancer serum and tumours: a biomarker study.
Albrethsen J; Bøgebo R; Gammeltoft S; Olsen J; Winther B; Raskov H
BMC Cancer; 2005 Jan; 5():8. PubMed ID: 15656915
[TBL] [Abstract][Full Text] [Related]
2. Elevation of human alpha-defensins and S100 calcium-binding proteins A8 and A9 in tear fluid of patients with pterygium.
Zhou L; Beuerman RW; Ang LP; Chan CM; Li SF; Chew FT; Tan DT
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2077-86. PubMed ID: 19168894
[TBL] [Abstract][Full Text] [Related]
3. Human neutrophil peptides 1, 2 and 3 (HNP 1-3): elevated serum levels in colorectal cancer and novel marker of lymphatic and hepatic metastasis.
Kemik O; Kemik AS; Sumer A; Begenik H; Purisa S; Tuzun S
Hum Exp Toxicol; 2013 Feb; 32(2):167-71. PubMed ID: 21669914
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of human neutrophil peptide-1, -2 and -3 as serum markers for colorectal cancer.
van den Broek I; Sparidans RW; Engwegen JY; Cats A; Depla AC; Schellens JH; Beijnen JH
Cancer Biomark; 2010; 7(2):109-15. PubMed ID: 21178269
[TBL] [Abstract][Full Text] [Related]
5. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
Geng X; Wang F; Li YG; Zhu GP; Zhang WM
J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
[TBL] [Abstract][Full Text] [Related]
6. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
[TBL] [Abstract][Full Text] [Related]
7. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
[TBL] [Abstract][Full Text] [Related]
8. [Establishment of serum protein pattern model for screening pancreatic cancers by SELDI-TOF-MS technique].
Ma N; Ge CL; Luan FM; Hu CJ; Li YZ; Liu YF
Zhonghua Wai Ke Za Zhi; 2008 Jun; 46(12):932-5. PubMed ID: 19035154
[TBL] [Abstract][Full Text] [Related]
9. Proteomics in the diagnosis of hepatocellular carcinoma: focus on high risk hepatitis B and C patients.
El-Aneed A; Banoub J
Anticancer Res; 2006; 26(5A):3293-300. PubMed ID: 17094443
[TBL] [Abstract][Full Text] [Related]
10. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS
Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431
[TBL] [Abstract][Full Text] [Related]
11. Extracellular and transmembrane region of a podocalyxin-like protein 1 fragment identified from colon cancer cell lines.
Ito T; Maki N; Hazeki O; Sasaki K; Nekooki M
Cell Biol Int; 2007 Dec; 31(12):1518-24. PubMed ID: 17719804
[TBL] [Abstract][Full Text] [Related]
12. Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysis.
Ménard C; Johann D; Lowenthal M; Muanza T; Sproull M; Ross S; Gulley J; Petricoin E; Coleman CN; Whiteley G; Liotta L; Camphausen K
Cancer Res; 2006 Feb; 66(3):1844-50. PubMed ID: 16452246
[TBL] [Abstract][Full Text] [Related]
13. [Surface enhanced laser desorption/ionization time-of-flight mass spectrometry profiling of serum in detection of laryngeal squamous cell carcinoma and the progression to lymph node metastasis].
Cheng L; Zhou L; Tao L; Zhang M; Cui JF; Liu YK
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(36):2526-30. PubMed ID: 18067823
[TBL] [Abstract][Full Text] [Related]
14. Human neutrophil peptides 1, 2 and 3 are biochemical markers for metastatic colorectal cancer.
Albrethsen J; Møller CH; Olsen J; Raskov H; Gammeltoft S
Eur J Cancer; 2006 Nov; 42(17):3057-64. PubMed ID: 17015013
[TBL] [Abstract][Full Text] [Related]
15. Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC-MS/MS.
Heo SH; Lee SJ; Ryoo HM; Park JY; Cho JY
Proteomics; 2007 Dec; 7(23):4292-302. PubMed ID: 17963278
[TBL] [Abstract][Full Text] [Related]
16. Clinical proteomics in breast cancer: a review.
Gast MC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
[TBL] [Abstract][Full Text] [Related]
17. Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling.
Ehmann M; Felix K; Hartmann D; Schnölzer M; Nees M; Vorderwülbecke S; Bogumil R; Büchler MW; Friess H
Pancreas; 2007 Mar; 34(2):205-14. PubMed ID: 17312459
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
[TBL] [Abstract][Full Text] [Related]
19. Identification of serum biomarkers for canine B-cell lymphoma by use of surface-enhanced laser desorption-ionization time-of-flight mass spectrometry.
Gaines PJ; Powell TD; Walmsley SJ; Estredge KL; Wisnewski N; Stinchcomb DT; Withrow SJ; Lana SE
Am J Vet Res; 2007 Apr; 68(4):405-10. PubMed ID: 17397297
[TBL] [Abstract][Full Text] [Related]
20. Liquid chromatography mass spectrometry for quantifying plasma lysophospholipids: potential biomarkers for cancer diagnosis.
Murph M; Tanaka T; Pang J; Felix E; Liu S; Trost R; Godwin AK; Newman R; Mills G
Methods Enzymol; 2007; 433():1-25. PubMed ID: 17954226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]